Oculis Holding AG

NASDAQ: OCS
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#9934
Country Rank
#137
Market Cap
965.25 M
Price
17.7
Change (%)
0.34%
Volume
7,983

Oculis Holding AG's latest marketcap:

965.25 M

As of 08/04/2025, Oculis Holding AG's market capitalization has reached $965.25 M. According to our data, Oculis Holding AG is the 9934th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 965.25 M
Revenue (ttm) 847,333
Net Income (ttm) -116,405,905
Shares Out 54.53 M
EPS (ttm) -2.69
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/26/2025
Market Cap Chart
Data Updated: 08/04/2025

Oculis Holding AG's yearly market capitalization.

Oculis Holding AG has seen its market value grow from $158.9 M to $965.25 M since 2021, representing a total increase of 507.45% and an annual compound growth rate (CAGR) of 65.04%.
Date Market Cap($) Change (%) Global Rank
08/04/2025 $965.25 M 35.37% 9934
12/31/2024 $713.06 M 73.5% 10706
12/29/2023 $411 M 148.15% 14305
12/30/2022 $165.63 M 4.23% 19147
12/28/2021 $158.9 M 20217

Company Profile

About Oculis Holding AG

Oculis Holding AG is a clinical-stage biopharmaceutical company focused on developing innovative treatments for ophthalmic diseases. Headquartered in Zug, Switzerland, the company operates internationally, with a presence in Iceland and other regions.

Key Product Candidates

  • OCS-01: A topical dexamethasone optireach formulation currently in Phase 3 clinical trials for diabetic macular edema.
  • OCS-02: A topical biologic candidate in Phase 2b clinical trials targeting dry eye disease.
  • OCS-05: A neuroprotective agent with potential applications in glaucoma, dry age-related macular degeneration, diabetic retinopathy, and acute optic neuritis.

Company Background

Founded in 2017, the company was originally named Oculis SA before rebranding to Oculis Holding AG in March 2023.

Frequently Asked Questions

  • What is Oculis Holding AG's (OCS) current market cap?
    As of 08/04/2025, Oculis Holding AG (including the parent company, if applicable) has an estimated market capitalization of $965.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Oculis Holding AG global market capitalization ranking is approximately 9934 as of 08/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.